Literature DB >> 20707805

Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines.

Osamu Kimura1, Takeshi Takahashi, Naoto Ishii, Yuki Inoue, Yoshiyuki Ueno, Takayuki Kogure, Koji Fukushima, Masaaki Shiina, Yoko Yamagiwa, Yasuteru Kondo, Jun Inoue, Eiji Kakazu, Takao Iwasaki, Naoki Kawagishi, Tooru Shimosegawa, Kazuo Sugamura.   

Abstract

Accumulating evidence suggests that cancer stem cells (CSC) play an important role in tumorigenicity. Epithelial cell adhesion molecule (EpCAM) is one of the markers that identifies tumor cells with high tumorigenicity. The expression of EpCAM in liver progenitor cells prompted us to investigate whether CSC could be identified in hepatocellular carcinoma (HCC) cell lines. The sorted EpCAM(+) subpopulation from HCC cell lines showed a greater colony formation rate than the sorted EpCAM(-) subpopulation from the same cell lines, although cell proliferation was comparable between the two subpopulations. The in vivo evaluation of tumorigenicity, using supra-immunodeficient NOD/scid/γc(null) (NOG) mice, revealed that a smaller number of EpCAM(+) cells (minimum 100) than EpCAM(-) cells was necessary for tumor formation. The bifurcated differentiation of EpCAM(+) cell clones into both EpCAM(+) and EpCAM(-) cells was obvious both in vitro and in vivo, but EpCAM(-) clones sustained their phenotype. These clonal analyses suggested that EpCAM(+) cells may contain a multipotent cell population. Interestingly, the introduction of exogenous EpCAM into EpCAM(+) clones, but not into EpCAM(-) clones, markedly enhanced their tumor-forming ability, even though both transfectants expressed a similar level of EpCAM. Therefore, the difference in the tumor-forming ability between EpCAM(+) and EpCAM(-) cells is probably due to the intrinsic biological differences between them. Collectively, our results suggest that the EpCAM(+) population is biologically quite different from the EpCAM(-) population in HCC cell lines, and preferentially contains a highly tumorigenic cell population with the characteristics of CSC.
© 2010 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20707805     DOI: 10.1111/j.1349-7006.2010.01661.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  40 in total

Review 1.  Cancer stem cell detection and isolation.

Authors:  Meysam Moghbeli; Faezeh Moghbeli; Mohammad Mahdi Forghanifard; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

Review 2.  Liver cancer stem cell markers: Progression and therapeutic implications.

Authors:  Jing-Hui Sun; Qing Luo; Ling-Ling Liu; Guan-Bin Song
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery.

Authors:  Timothy E Andrews; Dan Wang; Daniel A Harki
Journal:  Drug Deliv Transl Res       Date:  2013-04       Impact factor: 4.617

Review 4.  Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Mei Wang
Journal:  World J Hepatol       Date:  2015-01-27

5.  Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research.

Authors:  Myoung-Eun Han; Tae-Yong Jeon; Sun-Hwi Hwang; Young-Suk Lee; Hyun-Jung Kim; Hye-Eun Shim; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Chi-Dug Kang; Sae-Ock Oh
Journal:  Cell Mol Life Sci       Date:  2011-03-30       Impact factor: 9.261

6.  TGF-β1 pathway affects the protein expression of many signaling pathways, markers of liver cancer stem cells, cytokeratins, and TERT in liver cancer HepG2 cells.

Authors:  Xin-Hong Wang; Ming-Na Liu; Xun Sun; Chun-Huan Xu; Jing Liu; Jing Chen; Rui-Ling Xu; Bao-Xin Li
Journal:  Tumour Biol       Date:  2015-10-13

7.  Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.

Authors:  Lige Qiu; Hailiang Li; Sirui Fu; Xiaofang Chen; Ligong Lu
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

Review 8.  Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers.

Authors:  Regina Cheuk-Lam Lo; Irene Oi-Lin Ng
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

Review 9.  Role of liver stem cells in hepatocarcinogenesis.

Authors:  Lei-Bo Xu; Chao Liu
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

10.  High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.

Authors:  Curtis J Henrich; Anuradha Budhu; Zhipeng Yu; Jason R Evans; Ekaterina I Goncharova; Tanya T Ransom; Xin W Wang; James B McMahon
Journal:  Chem Biol Drug Des       Date:  2013-08       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.